Global vaccine equity: The G7's commitment and challenges

Yudai Kaneda; Kenzo Takahashi; Akihiko Ozaki; Tetsuya Tanimoto

doi:10.35772/ghmo.2023.01006

この記事には本公開記事があります。本公開記事を参照してください。
引用する場合も本公開記事を引用してください。

Global vaccine equity: The G7's commitment and challenges

Yudai Kaneda, Kenzo Takahashi, Akihiko Ozaki, Tetsuya Tanimoto

著者情報

キーワード: G7 Hiroshima Summit, global vaccine equity, COVID-19, COVAX, Japan

ジャーナルフリー早期公開

論文ID: 2023.01006

DOI https://doi.org/10.35772/ghmo.2023.01006

この記事には本公開記事があります。

The final version of this article is now available: Vol. 3 (2023), No. 1 pp. 56-57

詳細

抄録

The “Hiroshima Vision”, unveiled at the G7 Hiroshima Summit in 2023, leaves room for enhancement in the specific content of equitable global vaccine distribution plans. Despite the efforts of COVID-19 Vaccines Global Access (COVAX), vaccine supply faces severe disparities, with high-income countries receiving a disproportionately larger share. To mitigate future public health crises, mechanisms proven by past instances, such as establishing regional vaccine hubs, promoting technology transfers, and considering early patent rights relinquishment, need to be implemented. Correcting vaccine inequity necessitates learning from the COVID-19 pandemic and demands global cooperation and consensus from the G7.

責任著者(Corresponding author)

J-STAGEへの登録はこちら（無料）